Aili Wang Selected Research

human CHI3L1 protein

9/2017	YKL-40 is a novel biomarker for predicting hypertension incidence among prehypertensive subjects: A population-based nested case-control study in China.
11/2016	YKL-40 Level and Hypertension Incidence: A Population-Based Nested Case-Control Study in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aili Wang Research Topics

Disease

58	Ischemic Stroke 02/2022 - 06/2014
23	Stroke (Strokes) 02/2022 - 07/2016
15	Inflammation (Inflammations) 01/2022 - 09/2010
14	Hypertension (High Blood Pressure) 01/2021 - 05/2012
7	Neoplasms (Cancer) 03/2022 - 02/2017
6	Atherosclerosis 01/2021 - 11/2016
5	Asthma (Bronchial Asthma) 01/2019 - 01/2014
4	Cognitive Dysfunction 01/2022 - 04/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
3	Coenzyme Q10 Deficiency 01/2022 - 01/2020
3	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2014
3	Heart Failure 01/2021 - 01/2018
3	Pneumonia (Pneumonitis) 01/2020 - 01/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 01/2014
3	Prehypertension 09/2017 - 04/2011
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2022 - 01/2021
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2022 - 01/2020
2	Starvation 01/2021 - 09/2019
2	Reperfusion Injury 01/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 11/2017
2	Bacterial Infections (Bacterial Infection) 09/2019 - 12/2017
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 08/2017
2	Infections 01/2019 - 03/2002
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2018
2	Abdominal Obesity 09/2018 - 06/2017
2	Diabetes Mellitus 08/2017 - 08/2017
2	Body Weight (Weight, Body) 08/2017 - 06/2013
2	Respiratory Hypersensitivity 12/2016 - 12/2015
2	Allergic Rhinitis 01/2015 - 01/2014
2	Insulin Resistance 05/2012 - 09/2010
1	Propofol Infusion Syndrome 11/2022
1	ST Elevation Myocardial Infarction 03/2022
1	Thrombosis (Thrombus) 03/2022
1	Hypotension (Low Blood Pressure) 03/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2022
1	Nervous System Diseases (Neurological Disorders) 10/2021

Drug/Important Bio-Agent (IBA)

46	Antihypertensive Agents (Antihypertensives)IBA 02/2022 - 11/2016
27	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2010
9	LipidsIBA 10/2021 - 06/2013
8	C-Reactive ProteinIBA 01/2021 - 06/2013
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2017
4	HDL CholesterolIBA 07/2019 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 04/2018 - 06/2013
4	OvalbuminIBA 12/2015 - 01/2014
3	Protons (Proton)IBA 01/2022 - 01/2020
3	Growth Differentiation Factor 15IBA 01/2022 - 01/2019
3	Netrin-1IBA 10/2021 - 01/2019
3	EnzymesIBA 01/2021 - 06/2017
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 08/2017
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
3	Galectin 3 (LGALS3)IBA 12/2020 - 01/2018
3	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2020 - 12/2017
3	InterleukinsIBA 12/2016 - 01/2014
2	theasinensin AIBA 03/2022 - 09/2018
2	LactoferrinIBA 03/2022 - 09/2018
2	UbiquinoneIBA 01/2022 - 01/2020
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022 - 01/2021
2	Neuroprotective AgentsIBA 01/2022 - 10/2021
2	Choline (Choline Chloride)IBA 10/2021 - 01/2021
2	Betaine (C.B.B.)FDA Link 10/2021 - 01/2021
2	ImmunosorbentsIBA 01/2021 - 11/2020
2	Cystatin CIBA 01/2021 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2020
2	pro-brain natriuretic peptide (1-76)IBA 12/2020 - 12/2017
2	Uric Acid (Urate)IBA 11/2020 - 11/2016
2	CreatinineIBA 11/2020 - 01/2018
2	EndostatinsIBA 04/2020 - 01/2020
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020 - 01/2018
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020 - 11/2017
2	Oxygen (Dioxygen)IBA 01/2020 - 10/2016
2	Deoxyribonucleases (DNase)FDA Link 12/2019 - 04/2019
2	AntibodiesIBA 10/2019 - 01/2019
2	CathelicidinsIBA 09/2019 - 01/2019
2	Messenger RNA (mRNA)IBA 09/2019 - 01/2019
2	Complement System Proteins (Complement)IBA 01/2019 - 12/2016
2	Angiotensin IIIBA 01/2019 - 06/2013
2	N-propionylprocainamideIBA 01/2019 - 09/2018
2	HomocysteineIBA 01/2019 - 01/2017
2	Atrial Natriuretic Factor (ANF)IBA 01/2019 - 06/2017
2	Antimicrobial Cationic PeptidesIBA 01/2019 - 12/2017
2	ORALIT (ORS)IBA 01/2019 - 01/2014
2	oxidized low density lipoproteinIBA 01/2018 - 01/2014
2	human CHI3L1 proteinIBA 09/2017 - 11/2016
2	Interleukin-17 (Interleukin 17)IBA 12/2016 - 01/2015
2	Interleukin-13IBA 01/2015 - 01/2014
2	interleukin-21 (interleukin 21)IBA 01/2015 - 01/2014
2	SelectinsIBA 01/2014 - 06/2013
2	Triglycerides (Triacylglycerol)IBA 01/2014 - 01/2014
1	Propofol (Diprivan)FDA LinkGeneric 11/2022
1	AnticoagulantsIBA 01/2022
1	ThrombomodulinIBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2021
1	CholesterolIBA 10/2021
1	Complement C3 (C3 Complement)IBA 01/2021

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 03/2022 - 09/2018
1	Percutaneous Coronary Intervention 03/2022
1	Stents 03/2022
1	Anesthesia 01/2021